Cancer Patients Across the U.S. to Benefit from GenesisCare's Partnership with ViewRay, Inc.
As a team, including ViewRay, The Pancreatic Cancer Research Fund, and the University of Oxford, we've already seen compelling results from the Compassionate Access Programme (in the UK)."
- As a team, including ViewRay, The Pancreatic Cancer Research Fund, and the University of Oxford, we've already seen compelling results from the Compassionate Access Programme (in the UK)."
- In addition, by enabling continuous tracking of the target and surrounding healthy tissue, MRIdian can fluctuate the radiation beam if the patient moves.
- We are excited our maturing partnership with GenesisCare will continue to revolutionize the radiation oncology landscape."
- With more than 440 oncology and cardiology centers, GenesisCare offers radiotherapy at centers across Europe, Australia, and the United States.